Abeona Therapeutics, Inc. (ABEO)
2.495
-1.68
(-40.17%)
USD |
NASDAQ |
Nov 09, 11:48
Abeona Therapeutics Price to Book Value : 1.115 for Nov. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 1.864 |
| November 05, 2026 | 1.747 |
| November 04, 2026 | 1.886 |
| November 03, 2026 | 1.899 |
| November 02, 2026 | 1.899 |
| October 30, 2026 | 1.944 |
| October 29, 2026 | 2.038 |
| October 28, 2026 | 2.033 |
| October 27, 2026 | 1.989 |
| October 26, 2026 | 1.926 |
| October 23, 2026 | 1.966 |
| October 22, 2026 | 1.998 |
| October 21, 2026 | 2.015 |
| October 20, 2026 | 2.056 |
| October 19, 2026 | 1.971 |
| October 16, 2026 | 1.980 |
| October 15, 2026 | 2.078 |
| October 14, 2026 | 1.948 |
| October 13, 2026 | 2.020 |
| October 12, 2026 | 2.190 |
| October 09, 2026 | 2.208 |
| October 08, 2026 | 2.216 |
| October 07, 2026 | 2.270 |
| October 06, 2026 | 2.239 |
| October 05, 2026 | 2.284 |
| Date | Value |
|---|---|
| October 02, 2026 | 2.248 |
| October 01, 2026 | 2.239 |
| September 30, 2026 | 2.346 |
| September 29, 2026 | 2.306 |
| September 28, 2026 | 2.364 |
| September 25, 2026 | 2.413 |
| September 24, 2026 | 2.426 |
| September 23, 2026 | 2.471 |
| September 22, 2026 | 2.601 |
| September 21, 2026 | 2.534 |
| September 18, 2026 | 2.489 |
| September 17, 2026 | 2.498 |
| September 16, 2026 | 2.400 |
| September 15, 2026 | 2.444 |
| September 14, 2026 | 2.426 |
| September 11, 2026 | 2.420 |
| September 10, 2026 | 2.449 |
| September 09, 2026 | 2.587 |
| September 08, 2026 | 2.614 |
| September 04, 2026 | 2.681 |
| September 03, 2026 | 2.65 |
| September 02, 2026 | 2.659 |
| September 01, 2026 | 2.672 |
| August 31, 2026 | 2.614 |
| August 28, 2026 | 2.646 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ultragenyx Pharmaceutical, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 2.668 |
| Alnylam Pharmaceuticals, Inc. | 5.785 |
| Anika Therapeutics, Inc. | 1.430 |
| Savara, Inc. | 7.077 |
Price to Book Value Related Metrics
| PS Ratio | 5.449 |
| Price | 2.495 |
| Earnings Yield | -44.99% |
| Market Cap | 142.78M |